Ulrike Diesterbeck
VEROVACCiNES
13 profile visitsSpeakerCompanies/Industry
My organisation
VEROVACCiNES has developed a next-generation agile vaccine platform that enables rapid development of vaccines tailored to pathogen dynamics and geographically different strains, delivering faster availability, broader protection, improved scalability, and reduced development risk compared with classic vaccines. The company internally develops high-value vaccines with strong differentiation and validated its platform through the positive opinion of EMA and subsequent EU-wide marketing authorization of the VeroBlue-3 bluetongue virus serotype 3 vaccine. With this milestone, VEROVACCiNES has matured into a fully integrated vaccine developer capable of rapidly generating, developing, and registering vaccines across the EU.
About me
Additional questions
Interests
VaccinesRegulatory AffairsOther biologicalsLivestockFinancing / Investment / FundingEnabling technology (assay, delivery, formulation, manufacturing, ...)
Speaker sessions (1)
Wednesday, 20 May 2026
14:00 - 14:45
Masterclass 1: The Unified Vaccine Platform: A Standardized Framework for Versatile and Rapid Animal Vaccine Development:
Location:BMCC - 3rd Floor - Pigeon RoomTrack:Masterclass
Analogous to a Swiss Army knife, where a single standardized design supports multiple functions, the Unified Vaccine Platform (UVP) applies one coherent technological framework to a broad range of veterinary vaccine applications.
Sign-ups available from 1 Apr 2026, 00:00 to 20 May 2026, 14:45